Skip to main navigation
logo
  • Overview
  • News & Events
    • Press Releases
    • Calendar of Events
    • Presentations
  • Financial Info
    • SEC Filings
    • Supplemental Financial Information
  • Corporate Governance
    • Documents & Charters
    • Leadership
    • Board of Directors
    • Committee Composition
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor Resources
    • FAQ
    • Information Requests
    • IR Contact

Lantheus Holdings to Host Third Quarter 2019 Earnings Conference Call on October 31, 2019 at 8:00 a.m. Eastern Time

  • Read more about Lantheus Holdings to Host Third Quarter 2019 Earnings Conference Call on October 31, 2019 at 8:00 a.m. Eastern Time

Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company

  • Read more about Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company

Lantheus Holdings to Present at the Wells Fargo Securities 2019 Healthcare Conference

  • Read more about Lantheus Holdings to Present at the Wells Fargo Securities 2019 Healthcare Conference

Lantheus Holdings, Inc. Reports Second Quarter 2019 Financial Results

  • Read more about Lantheus Holdings, Inc. Reports Second Quarter 2019 Financial Results

Lantheus Holdings to Host Second Quarter 2019 Earnings Conference Call on July 25, 2019 at 8:00 a.m. Eastern Time

  • Read more about Lantheus Holdings to Host Second Quarter 2019 Earnings Conference Call on July 25, 2019 at 8:00 a.m. Eastern Time

Lantheus Announces Presentation of New Patient Outcomes Data for DEFINITY® at the American Society of Echocardiography 2019 Annual Scientific Sessions

  • Read more about Lantheus Announces Presentation of New Patient Outcomes Data for DEFINITY® at the American Society of Echocardiography 2019 Annual Scientific Sessions

Lantheus Announces New Patient Outcomes Data for DEFINITY® to be Presented at the American Society of Echocardiography 2019 Annual Scientific Sessions

  • Read more about Lantheus Announces New Patient Outcomes Data for DEFINITY® to be Presented at the American Society of Echocardiography 2019 Annual Scientific Sessions

Lantheus Announces Strategic Collaboration with NanoMab to Provide a Novel Biomarker for Clinical Development and Management of Immuno-Oncology Therapies

  • Read more about Lantheus Announces Strategic Collaboration with NanoMab to Provide a Novel Biomarker for Clinical Development and Management of Immuno-Oncology Therapies

Lantheus Holdings, Inc. to Present at the Jefferies 2019 Global Healthcare Conference

  • Read more about Lantheus Holdings, Inc. to Present at the Jefferies 2019 Global Healthcare Conference

Lantheus Holdings, Inc. to Present at the 2019 UBS Global Healthcare Conference

  • Read more about Lantheus Holdings, Inc. to Present at the 2019 UBS Global Healthcare Conference

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Current page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Site - Shareholder Services

Print Page
RSS Feeds
Email Alerts
  • Copyright © 2025 Lantheus Holdings, Inc. All rights reserved.